XML 30 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY/ DEFICIT - USD ($)
$ in Thousands
Total
Previously Reported
Revision of Prior Period, Adjustment
Common Stock Outstanding
Common Stock Outstanding
Previously Reported
Common Stock Outstanding
Revision of Prior Period, Adjustment
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Revision of Prior Period, Adjustment
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
Previously Reported
Beginning balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2022 129,148,393 29,521,810 99,626,583                    
Beginning balance, temporary equity at Dec. 31, 2022 $ 480,631 $ 480,631                      
Increase (Decrease) in Temporary Equity [Roll Forward]                          
Exercise of a warrant, Series C and D Preferred Stock (in shares) 594,309                        
Exercise of a warrant, Series C and D Preferred Stock $ 5,890                        
In-kind payment of preferred dividend $ 241,529                        
Conversion of preferred stock into common stock (in shares) (129,742,702)                        
Conversion of preferred stock into common stock $ (728,050)                        
Ending balance, Redeemable Convertible Preferred Stock (in shares) at Dec. 31, 2023 0                        
Ending balance, temporary equity at Dec. 31, 2023 $ 0                        
Beginning balance, Common Stock Outstanding (in shares) at Dec. 31, 2022       10,422,051 2,382,358 8,039,693              
Beginning balance at Dec. 31, 2022 (428,722) $ (428,722) $ 0 $ 1 $ 0 $ 1 $ 24,782 $ 24,783 $ (1) $ (456,245) $ (456,245) $ 2,740 $ 2,740
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation expense 14,957           14,957            
RSA vesting (in shares)       2,535,825                  
Repurchase of equity instruments (in shares)       (771,141)                  
Repurchase of equity instruments (7,650)           (7,650)            
Net loss (134,098)                 (134,098)      
Issuance of common stock upon exercise of options and vesting of RSUs (in shares)       1,661,698                  
Issuance of common stock upon exercise of options and vesting of RSUs 2,550           2,550            
In-kind payment of preferred dividend (241,529)                 (241,529)      
Conversion of preferred stock into common stock (in shares)       153,895,644                  
Conversion of preferred stock into common stock 728,050     $ 15     728,035            
Recapitalization, net of transaction expenses (in shares)       28,898,374                  
Recapitalization, net of transaction expenses 236,973     $ 3     236,970            
Forward Purchase Agreement prepayment (60,547)           (60,547)            
Reclassification of warrants to equity 4,863           4,863            
Other comprehensive income, net 0                        
Foreign currency translation $ (376)                     (376)  
Ending balance, Common Stock Outstanding (in shares) at Dec. 31, 2023 196,642,451     196,642,451                  
Ending balance at Dec. 31, 2023 $ 114,471     $ 19     943,960     (831,872)   2,364  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Stock-based compensation expense 13,342           13,342            
Repurchase of equity instruments (48)           (48)            
Net loss (137,731)                 (137,731)      
Forward Purchase Agreement Settlement $ 24,084           24,084            
Issuance of common stock upon exercise of options and vesting of RSUs (in shares) 206,000     1,199,774                  
Issuance of common stock upon exercise of options and vesting of RSUs $ 300           300            
Treasury Shares (in shares)       (2,926,514)                  
Other comprehensive income, net (1,096)                     (1,096)  
Foreign currency translation $ 125                     125  
Ending balance, Common Stock Outstanding (in shares) at Dec. 31, 2024 194,915,711     194,915,711                  
Ending balance at Dec. 31, 2024 $ 13,447     $ 19     $ 981,638     $ (969,603)   $ 1,393